Inventor · disambiguated record
Young Jin Ham
Also filed as: HAM YOUNG JIN
14 granted patents·6 pending applications·85 citations·filing 2001–2022
90Inventor score
Files withLG CHEMICAL LTD6SIM TAE BO5HANMI PHARM IND CO LTD4HANMI HOLDINGS CO LTD1HANMI PHARMACEUTICAL CO LTD1
Top patents by PatentIndex Score
20 records- 0191US8754209B2Indazole derivatives or pharmaceutically acceptable salts thereof as protein kinase inhibitors for proliferative diseases treatment, and a pharmaceutical composition containing the same as an active ingredientSIM TAE BO·Filed 2009·Granted Jun 17, 2014·30 cites·8 claims
- 0287US10280154B2Pyrimidine compound and pharmaceutical use thereofHANMI PHARM IND CO LTD·Filed 2018·Granted May 7, 2019·4 cites·18 claims
- 0385US10519141B2Pyrimidine compound and pharmaceutical use thereofHANMI PHARM IND CO LTD·Filed 2018·Granted Dec 31, 2019·3 cites·11 claims
- 0485US8329708B21,3,6-substituted indole derivatives having inhibitory activity for protein kinaseSIM TAE BO·Filed 2010·Granted Dec 11, 2012·5 cites·11 claims
- 0585US8003658B2Quinazoline derivatives for inhibiting cancer cell growth and method for the preparation thereofHANMI HOLDINGS CO LTD·Filed 2005·Granted Aug 23, 2011·7 cites·11 claims
- 0681US8586580B22,7-substituted thieno[3,2-d] pyrimidine compounds as protein kinase inhibitorsSIM TAE BO·Filed 2010·Granted Nov 19, 2013·8 cites·7 claims
- 0778US8765749B21,6-disubstituted indole compounds as protein kinase inhibitorsSIM TAE BO·Filed 2010·Granted Jul 1, 2014·3 cites·7 claims
- 0876US7625926B2P-glycoprotein inhibitor, method for preparing the same and pharmaceutical composition comprising the sameHANMI PHARM IND CO LTD·Filed 2004·Granted Dec 1, 2009·9 cites·9 claims
- 0976US6388091B1Process for the preparation of 1,2,3,9-tetrahydro-9-methyl-3-{(2-methyl-1H-imidazol-1-yl)methyl}-4H-carbazol-4-oneHANMI PHARM IND CO LTD·Filed 2001·Granted May 14, 2002·12 cites·9 claims
- 1073US8648089B21,3,6-substituted indole derivatives having inhibitory activity for protein kinaseKOREA INST SCI & TECH·Filed 2012·Granted Feb 11, 2014·1 cites·3 claims
- 1166US8999973B2Thieno[3,2-d]pyrimidine derivatives having inhibitory activity on protein kinasesSON JUNG BEOM·Filed 2011·Granted Apr 7, 2015·2 cites·14 claims
- 1265US2024317739A1Novel urea derivative compound as ron inhibitorLG CHEMICAL LTD·Filed 2022·Application pending·0 cites
- 1365US2024300944A1Novel urea derivative compound as ron inhibitorLG CHEMICAL LTD·Filed 2022·Application pending·0 cites
- 1464US2024425480A1Novel pyridine derivative compound as ron inhibitorLG CHEMICAL LTD·Filed 2022·Application pending·0 cites
- 1564US2024316017A1Novel pyridine derivative compound as ron inhibitorLG CHEMICAL LTD·Filed 2022·Application pending·0 cites
- 1657US10112954B2Bicyclic heteroaryl derivatives having inhibitory activity for protein kinaseJUNG SEUNG HYUN·Filed 2011·Granted Oct 30, 2018·1 cites·7 claims
- 1756US2024293386A1Novel compound as protein kinase inhibitorLG CHEMICAL LTD·Filed 2022·Application pending·0 cites
- 1854US2024150325A1Novel compound as protein kinase inhibitorsLG CHEMICAL LTD·Filed 2022·Application pending·0 cites
- 1948US10781217B2Imidazopyridazine compoundHANMI PHARMACEUTICAL CO LTD·Filed 2018·Granted Sep 22, 2020·0 cites·13 claims
- 2037US9422307B22,4,7-substituted thieno[3,2-d]pyrimidine compounds as protein kinase inhibitorsSIM TAE BO·Filed 2010·Granted Aug 23, 2016·0 cites·12 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →